Advertisement
Advertisement

SNY

SNY logo

Sanofi - ADR

47.02
USD
Sponsored
+0.82
+1.77%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

47.02

+0.01
+0.02%

SNY Earnings Reports

Positive Surprise Ratio

SNY beat 30 of 40 last estimates.

75%

Next Report

Date of Next Report
Apr 23, 2026
Estimate for Q1 26 (Revenue/ EPS)
$10.52B
/
$1.77
Implied change from Q4 25 (Revenue/ EPS)
-4.47%
/
+139.19%
Implied change from Q1 25 (Revenue/ EPS)
+6.27%
/
-1.12%

Sanofi - ADR earnings per share and revenue

On Jan 29, 2026, SNY reported earnings of 0.74 USD per share (EPS) for Q4 25, missing the estimate of 1.46 USD, resulting in a -49.05% surprise. Revenue reached 11.01 billion, compared to an expected 11.46 billion, with a -3.92% difference. The market reacted with a +0.94% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 1.77 USD, with revenue projected to reach 10.52 billion USD, implying an increase of 139.19% EPS, and decrease of -4.47% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Johnson & Johnson
Report Date
Jan 21, 2026 For Q4 25
Estimate
$2.46
Actual
$2.46
Surprise
-0.13%
FAQ
For Q4 2025, Sanofi - ADR reported EPS of $0.74, missing estimates by -49.05%, and revenue of $11.01B, -3.92% below expectations.
The stock price moved up 0.94%, changed from $45.77 before the earnings release to $46.20 the day after.
The next earning report is scheduled for Apr 23, 2026.
Based on 4 analysts, Sanofi - ADR is expected to report EPS of $1.77 and revenue of $10.52B for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement